New Jackson Lab CEO Cardon eyes expansion of Farmington campus, more spinoffs

With an eye toward possible expansion of The Jackson Laboratory for Genomic Medicine in Farmington, new spinoffs and possibly new hires down the road, longtime researcher and academic Dr. Lon Cardon will take the helm as president and CEO of the seven-year-old growing facility on Nov. 29.

The 56-year-old Cardon — who is currently the chief science strategic officer of California-based BioMarin Pharmaceutical Inc. — will replace current president and CEO Dr. Edison Liu.

Related Keywords

Farmington ,Connecticut ,United States ,Japan ,New Britain ,Shanghai ,China ,Yokohama ,Kanagawa ,Stanford University ,California ,Beijing ,University Of Connecticut ,Bar Harbor ,Maine ,Massachusetts ,Colorado ,Sacramento ,Ellsworth ,Japanese ,Lon Cardon ,Edison Liu ,Timothy Dattels ,Glaxosmithkline ,Jackson Laboratory For Genomic Medicine In Farmington ,Jackson Lab ,Uconn Health ,Biomarin Pharmaceutical Inc ,Department Of Mathematics At Stanford University ,Jackson Lab Farmington ,University Of Connecticut School Medicine ,Institute For Behavioral Genetics ,Jackson Lab Connecticut ,University Of Colorado ,Jackson Laboratory ,Jackson Laboratory Japan ,Genomic Medicine ,California Based Biomarin Pharmaceutical ,Hartford Business Journal ,Connecticut School ,General Biomics ,Rick Lopes ,D New Britain ,Biomarin Pharmaceutical ,Behavioral Genetics ,